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Bacteriophages (phages) are viruses that specifically parasitize on bacteria and are found 
almost everywhere. Phages Phi 29 and Q11 are both small phages found in soil that attack 
Bacillus hosts. Previous Phi 29 studies verified a covalently bonded protein at the 5’ end of its 
double-stranded linear DNA. Q11 may have a similar 5’ terminal protein, which blocks complete 
sequencing of that DNA region. Because Q11 and phi29 are both small short-tailed phages that 
infect similar hosts, it could be possible the proteins are structurally similar. In previous work, I 
have attempted to use restriction endonuclease and exonuclease enzyme digests to isolate the 
fragment of DNA containing a terminal protein. More recently, I have turned to PCR 
amplification, mass spectroscopy (MS) data, and comparing the amino acid sequence of the 
proteins to identify similarities and differences between phi29 and Q11’s respective terminal 
proteins. I was not able to successfully amplify and express Q11’s suspected terminal protein. 
However, through MS data and comparing amino acid sequences, it can be assumed they are not 
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Phi29 and Q11 are both small bacteriophages (possibly both in the Podovirales) that are 
found in the soil. Bacteriophages are one of the most abundant life forms found on the planet and 
exist in most ecosystems. Overall, some bacteriophages are very well studied in the literature. 
However, there is still plenty of research to do done. Most of the research done on phi29 and 
other small phages was done at the end of the 1970’s. Specifically, two researchers, Junetsu Ito 
and Clifford O. Yehle, published separate competing papers both in 1978 [1,2]. Both focused on 
phi29, which is a phage that affects certain strains of Bacillus bacteria and is thought to have a 
small tightly bound protein covalently bonded to the 5’ terminus of its double-stranded DNA 
genome. Terminal proteins (‘T-proteins’) are not commonly found in small phages, but are 
suggested to play an important part in infection. At the time of the 1978 research, there was very 
little known about the association between the protein and the phi29 chromosome, although 
today it has been studied widely. Ito and Yehle focused on the phage and the covalently bonded 
protein, while differing in some materials/methods, results, and discussion. Q11 is less well 
researched (though its DNA sequence has been determined), but is comparable to phi29 in that it 
could possibly have a protein on its 5’ end of its DNA.  
Both 1978 papers described preparing phage by infecting Bacillus amyloliquefaciens H. 
During their experiments, both Ito and Yehle treated the phage DNA and DNA-protein complex 
with lambda exonuclease and exonuclease III. Lambda exonuclease digests from the 5’ to 3’ 
ends of double stranded DNA (dsDNA), removing nucleotides resulting in degradation of the 




exonuclease that initiates at the 5’ end would not be able to digest from the 5'end if that end were 
blocked by a protein.  
Along with enzymatic approaches, other approaches Ito and Yehle did similarly included 
phosphorylation with polynucleotide kinase on the DNA, using EcoRI restriction endonucleases, 
radioactive labeling, and electrophoresis gels to locate, describe and characterize any changes to 
the DNA. Ito used many more restriction enzymes than Yehle, but used EcoRI as the main 
example. Through their various methods, both papers concluded that there is something blocking 
the 5’ end of the phi29 chromosome and they both agree that the protein is covalently bonded, as 
it cannot be easily removed.  
Since phi29 and Q11 are similar size phages, infecting similar host bacteria, we thought it 
reasonable to investigate the possibility of a T-protein on the Q11 genomic DNA. Previous work 
[3] resulted in the near-complete genomic DNA sequence of Q11, except for the 5’-end, which 
was limited due to some undescribed physical impediment to the progress of the DNA 
sequencing enzymes (DNA polymerase), which must use all the phage template in order to 
produce a complete sequence. Various other related sequencing methods also failed to supply a 
complete sequence, so it was assumed that something similar to a T-protein was present at the 
5’-end.  
The first approach our lab took to characterize and identify a T-protein was enzyme 
digests. This research was done in previous semesters and summer of 2019. Restriction enzymes 
(RE) and exonuclease enzymes were used to locate the T-protein and observe differences in 
migration patterns on DNA gels. This method had been established using phi29, and was 
attempted to replicate and reproduce results for Q11 [1,2]. The RE EcoRI and HindIII were used 




exonuclease were used to digest DNA fragments from the 5’ end.  It was predicted that 
unprotected 5' DNA fragment ends would be digested and be detectable as missing or smaller 
DNA bands in DNA electrophoresis gels.  Additionally, it was expected that a 5’ DNA terminus 
with a 'blocking protein' would be protected from digestion by exonuclease III and ƛ 
exonuclease, and show no mobility change in DNA gels. The results of this approach did not 
give a clear answer, so the approach shifted to PCR amplification and comparative analysis of 
data of phi29 and Q11.  
There are effectively complete DNA sequences for both Phi29 and QCM11, this allows 
us to pinpoint the T-protein gene and design primers for polymerase chain reaction (PCR), which 
can amplify the gene that encodes for the suspected T-protein. We wanted to amplify the gene in 
order to use the DNA to in subsequent experiments to express the protein in order to study and 
characterize it. I designed primers for Q11 and Phi29 T-protein genes using tools from the 
National Center for Biotechnology (NCBI).  Our PCR protocol was optimized using Integrated 
DNA’s technology’s article titled “Breaking PCR.” This aided in finding the appropriate 
concentrations for the needed variables of a PCR mixture (template DNA amount, primers 
amount, buffers, dNTPs, enzyme, etc) to help ensure the best outcome. Primers for phi29 had 
previously been designed and applied to phi29 DNA. Therefore, I wanted to compare the 
products of a Q11 PCR and a phi29 PCR.  
Furthermore, with this researched I wanted to compare the possible Q11 T-protein to 
phi29’s T-protein. Using data analysis and genomes published within the literature, we were able 
to use tools to compare the proteins without fully expressing them. This tactic allows further 




Bacteriophages are some of the most abundant organisms on earth, but most of the 
literature and other research looks at long-tailed phages. Both Q11 and phi29 are small phages 
and have short tails. That is, there is limited knowledge of how these phages differ from others in 
terms of genome, replication, and infection. The goal of this research is to identify and 
characterize a possible T-protein on the end of Q11 DNA, therefore, contributing to the 
understanding of these phages as a whole. Also, since phages are a natural predator of bacteria 
they have the potential to be used as an antibiotic therapy. The goal of this research is to identify 
and characterize a possible T-protein on the end of Q11 DNA, therefore, contributing to the 


















RESEARCH QUESTIONS  
❏ Is there a covalently attached protein on the 5’ end of bacteriophage Q11’s DNA?  
❏ Can we amplify and/or express the gene suspected to code for said protein?  
❏ If so, is the amplified gene or gene product similar to the phi29 T-protein? 
 
HYPOTHESES  
❏ A T-protein is present at the 5’ terminal of phage Q11 genomic DNA. 




















 I consistently used both phi29 (from the Félix d'Hérelle Reference Center for Bacterial 
Viruses of the Université Laval) and Q11 bacteriophages, which were collected from soil 
samples taken from a local urban planted prairie.  
 
Phage harvest and isolation:  
The phages were increased on host B. cereus or B. subtilis (for phi29), isolated and 
purified in the lab. Host bacteria was inoculated into nutrient broth (TSA: tryptic soy broth, 
Fisher Scientific) and shaken to allow growth to logarithmic host growth phase (approximately 2 
hours post inoculation, 30°C), characterized by cell doubling. Host B. cereus stays in the log 
phase for 2-3 hours after inoculation. Previous to preparing the host, a 'spot titre assay' is done 
using samples of the appropriate phage (Q11 or phi29) to determine the correct concentration of 
phage (phage:host ratio, MOI - 'multiplicity of infection') that will produce confluent plaques in 
platings. A high enough concentration of phage to completely clear (kill) a plate of bacteria is 
not used in the increase and harvest because of plaque overlap and decrease in susceptible host 
cell numbers. In contrast, too low of a phage concentration would not yield enough phage to 
harvest. Previous experience suggested an optimal phage dilution of 10^-2 or 10^-3 (in 100 uL, 
with 300 uL log-phase host) would produce plates with confluent plaques. I inoculated the host 
with the advised bacteriophage dilutions in 1.5 mL microfuge tubes. The mixture was held at 
room temperature for 10 minutes, then 30º for 10 minutes. Phage-host mixtures were then spread 
evenly onto 8-12 TSA plates, dried briefly and incubated at 30º overnight.  
The next day, 5 ml of TSB are used to remove the bacterial/ confluent plaque layer from 




Chloroform breaks up the cell membranes and other unwanted parts of the bacteria to allow low 
speed centrifugation separation of host components (pellet) from phage (supernatant lysate). 
After decanting the lysate, the remaining chloroform is extracted using an air vacuum system in 
order to protect the centrifuge tube materials used in the next time, high-speed 'ultra'-
centrifugation. The lysate is then portioned evenly and balanced in polycarbonate centrifuge 
tubes and subjected to ultracentrifugation for 2 hours and 30 minutes at 16,000Xg, 4°C. The viral 
particles sediment to the bottom of the centrifuge tube and form a pellet, leaving the supernatant 
mostly free of viral particles. The concentrated phage is called a high speed pellet (HSP) and is 
resuspended in a SM-buffer (10mM NaCl, 8mM MgSO4, 5mM Tris-HCl, pH 7.5, 2% gelatin) 
and stored at 4º C.    
 
Phage DNA isolation:  
 The first step in isolating DNA from the resuspended HSP is to eliminate any remaining 
host DNA from the sample. 2 µl of DNAse is added to 100 µl of HSP with 25 µl of DNAse 
buffer and 123 µl of distilled 'UV-treated' water. The solution is then incubated at 37º C for 60 
minutes. Proteinase K is added to destroy the DNAse enzyme. The proteinase K will also 
eliminate the phage coat protein and release the DNA. 250 µl of Proteinase K buffer is added to 
the DNAse/HSP sample along with 250 µg of Proteinase K. The sample is mixed by inversion 
and incubated at 65ºC for 120 minutes.  
 After incubation of proteinase K, phenol-chloroform-isoamyl alcohol (PCI-Fisher 
Scientific) extraction is used to purify the DNA from the destroyed coat protein. Equal volumes 
of PCI is added to each HSP-DNAse-Proteinase-K tube. Tubes are vortexed for 5 seconds and 




removed, combined with an equal volume of PCI and the process is repeated three times total. 
The final process of isolating phage DNA from the aqueous layer involves two ethanol 
precipitations to fully precipitate the DNA. Typically, 1/10 volume of 3M sodium acetate is 
added mixed by inversion or vortexed for 5 seconds. Then, 2 volumes of ice- cold 95% ethanol is 
added, followed by incubation on ice for 1 hour. Samples are next centrifuged for 10 minutes at 
max rpm (31,000 X g). All supernatant is decanted and centrifugation is repeated with 2 volumes 
70% ethanol.  The supernatant is removed and the DNA pellet is resuspended by vortexing for 5 
seconds in 100 µl of Tris-EDTA buffer (TE, Fisher Scientific), then held overnight at 4º C. 
Optimally, 2 ethanol precipitation steps are repeated on the sample the next day. After the 70% 
ethanol step, all ethanol is removed by vacuum evaporation (SpeedVac, Desiccator, or under 
nitrogen), leaving the DNA pellet, which is resuspended in water or TE.  
 I used the nanospectrometer to measure the concentration of DNA resolved. Absorbance 
levels A230, A260, A280, and A260/280 were all recorded to demonstrate the concentration and 
purity of DNA and to determine if any protein residue was left over. Also, the DNA would be 
run on a gel electrophoresis to visualize its condition for future experiments.  
 
Enzymatic Treatments:  
 The two restriction endonuclease enzymes used to fragment the DNA are HindIII and 
EcoRI. Depending on the concentration of DNA, 5-10 µl was combined with 2 µl of either 
HindIII or EcoRI  along with 2 µl of the respective 10x buffer, 1 µl of BSA, and 10 µl of 
distilled UV treated water and incubated at 37º C for 30 minutes. Immediately after, 1 µl of an 




buffer was added, followed by incubated at 37º C for 120 minutes. The DNA was then run on 
various standard 0.8% electrophoresis gels or pulse field gel electrophoresis.   
 
NCBI Data: 
 To collect molecular genomic data, I used The National Center for Biotechnology 
Information (NCBI). NCBI provides a variety of tools to analyze molecular data of genomes and 
amino acid sequences. The tools I used included PRIMERblast and PROTEINblast. For both 
tools, genomic data was searched for and found in the dataset. To identify the gene code for the 
T-protein, I searched “terminal protein” and a tagged area in the genome was identified. 
Furthermore, the amino acid sequence for those selected genes were also available the same way. 
To further compare the phages, are third Bacillus phage, VioletteMad (NCBI Accession: 
MN082624), was also identified using a wide search for “terminal protein”. The analysis of the 
three amino acid sequences in found in the results section.   
 
Polymerase Chain Reaction:  
 NCBI DNA database was used as a tool to design primers using the Q11 genome. 
PrimerBLAST is an application of NCBI that generates primers for targeting a specific gene. The 
full genome of Q11 and phi 29 is available on NCBI and the genes suspected to code for the T-
proteins are available for targeting. Following the protocol developed by our lab, I was able to 
design various sets of primers (upstream and downstream) to use for a PCR amplification of the 
gene. This PCR primer design protocol includes entering the gene desired and setting parameters 
for potential primers. I designed inside and outside sets of primers to see which could amplify 




Coalville, IA), resuspended as per recommendations and used in PCR reactions on isolated 
phage DNA templates. Figures 1 and 2 show the generated primers from NCBI compared to the 
gene responsible for coding the T-protein for Q11 and Phi29. 
 
Figure 1: Outside Q11 Primers Graphical View 
 
Figure 2: Inside Q11 Primers Graphical View 
 The PCR mix was made using 135 µl of distilled UV treated water, 25 µl of IBI RP010 
'10X Reaction' (No MgCl2) Buffer, 15 µl of MgCl2 IBI RP011 [25mM], 20 µl of Ultrapure 
dNTP Solution, and 5 µl of IBITaq (IBI Scientific, Dubuque, IA). This master mix was aliquoted 




added to each tube. Then, 1 µl of both a forward and reverse primer was added. The tubes were 
kept on ice the entire preparation time to ensure a reaction would not take place before starting 
the PCR reaction in the PCR machine. The samples were subjected to a '3-step PCR program' (1. 
94°C 1 min; 2. 94°C 40 sec; 3. 60°C 40 sec; 4. 75° 10 sec; 5. Go to '2' 29 times; 6. 75°C 5 min; 
7. Hold 4°C ).  PCR reactions are then frozen until ready to run on a standard gel electrophoresis.   
 
Mass Spectrometer Data Collection:  
 Purified DNA from both Phi29 and from Q11 were sent to The Protein Facility of the 
Iowa State University Office of Biotechnology (Ames, IA) for analysis by mass spectrometry. 
The Protein Facility offers 'tandem mass spectrometry' (LC-MS/MS) of submitted, purified 
proteins.  Our submissions were DNA with a small protein supposedly attached, a non-standard 
submission.  Standard outcomes were not assured. The LC-MS/MS system (Q Exactive™ 
Hybrid Quadrupole-Orbitrap Mass Spectrometer, Thermo Scientific) operates by initial 
separation of a very small volume (nanolitres) of protease digested protein fragments on a high-
pressure liquid chromatographic column.  Fragments exit the column according to solubility or 
molecular weight and are further fragmented and ionized, producing very small, charged 
molecules consisting of only several connected carbon atoms from what originated as a peptide 
backbone of a phage protein. Each tiny, charged fragment is induced to move at very high speed 
by powerful magnets past other magnets that 'sort' the fragments by size (mass) and charge and 
send them to a final collision with a target plate, which registers the location of each collision in 
reference to a center point, producing a 'fragmentation pattern'. From ISU: 'The resulting intact 
and fragmentation pattern is compared to a theoretical fragmentation to find peptides that can 




mass ratio of each particle. Based on 'reference collisions' by particles of known charge-to-mass 
ratio, the data points are compared to a computer-generated data-base of virtually all possible 
small carbon molecules (including isotopes) available for mass-spec analysts.  The output 
delivered to us was complex, but included a list of the top protein candidates (Tables 1 & 2) 
identified by the software. 
 
Expressing the T-proteins In-Vitro  
 For comparative purposes, we thought expressing the T-protein by themselves would be 
useful in suppliment of our other approaches. Since we did have the complete DNA sequences of 
both phages Q11 and Phi29, we also had access to the genes supposedly coding for either T-
protein.  Based on my 'outside' primer design, it was advised (by Walter) that we use the T-
protein gene sequences from Q11 and Phi29 to direct protein synthesis in 'cell free translation’ 
(in tubes) systems. We designed 'genes' for expression of each T-protein by adding on DNA 
coding for upstream (5’ Shine-Delgarno sequence, spacer DNA regions, ribosome RNA binding 
regions) and downstream (spacers, termination sequences, poly-A tails) to each T-protein gene 
sequence and ordering each product (gBLOCKs) from IDT (Coralville, IA).  The gBlocks were 
added as per manufacturer's recommendations to the New England Biologicals (Ipswich, MA) 
NEBExpress Cell-free E.coli Protein Synthesis System and allowed to synthesize protein at 37°C 
for 4 hours. Protein products (including internal controls) were analyzed by SDS-PAGE, initially 








 We expected that a covalently attached T-protein would protect DNA from exonuclease 
attack.  We also realized that smaller fragments of DNA would more easily reveal resultant size 
changes on standard DNA gels than would genome-length phage DNA.  In accordance with 
previous work, we produced smaller DNA fragments before digesting with exonucleases.   
The results of the exonuclease digests of previously endonuclease digested phage DNA using, 
and exonucleases did not suggest any significant differences in migration (size) of any of the 
DNA  band fragments. Figures 3 and 4 show Q11 DNA digested with the enzymes HindII ans 
EcoRI respectively.  In both images, the last two lanes of the gel have no evidence of bands still 
present after exposure to 3’ or 5’ exonucleases, suggesting a lack of terminal protein protection 
from exonuclease digestion.  
 
Figure 3: Q11 DNA digested with HindIII.  Lanes contain the following (L to R) 1. Q11 DNA 2.Q11 DNA + HindIII  3. Q11 






Figure 4: Q11 DNA digested with EcoRI  
 Lanes contain the following (L to R) 1. Q11 DNA + EcoRI 2. Q11 DNA + EcoRI+ 3’ exonuclease III 3. Q11 DNA + EcoRI + 
5’ lambda exonuclease 
The results of several PCR experiments only inconsistently amplified shorter regions of 
Q11 T-protein DNA for which the primers were designed (Figure 5). Full length Q11 (lane 7) 
and phi29 (lane 11) DNA templates both produced predicted PCR amplification products.  
Shorter segments of phi29 T-protein gene (lanes 8-10) were amplified.  However, comparable 
shorter sequences within the Q11 T-protein gene were not amplified (lanes 3-7).  Q11 was not 
able to be amplified consistently or strongly enough to draw a conclusion about the T-protein in 






Figure 5: PCR reaction results for Q11, phi29, and a control template.  
Lanes 1 & 12 contain 1 kb DNA marker. Lanes 2-7 contain Q11 with various primers. Lanes 8-10 contain phih29 
with primers. Lane 11 contains16sRNA positive control . 
 Figure 6, 7, and 8 show the results of a sequence-based protein comparative analysis 
(DOTlet: https://myhits.sib.swiss/cgi-bin/dotlet) of phi29 and Q11’s amino acid sequence for the 
suspected T-protein, as well as for Bacillus phage VioletteMad T-protein. The axis of the graphs 
represent the amino acid position of each protein. The lines on the graph demonstrate where 
there is similarity or identity between them. The gaps in the lines are areas that are not similar 
between the proteins. In Figure 6, you can see that Q11 and phi29 have overlap, however, there 
are large gaps. Figure 7 shows a similar pattern between VioletteMad and phi29. Lastly, in 
Figure 8, you can see how similar Q11 and VioletteMad are, with only small areas of 





Figure 6: Dot Plot Q11 vs. phi29 
 
 





Figure 8: Dot Plot Q11 vs. VioletteMad 
 
 Attempts to express DNA-synthesized (gBLOCKs) T-protein genes from known, 
complete genome DNA sequences of Q11 and phi29 continue, but show little conclusive 
evidence to date.  Figure 9 shows images of SDS-PAGE gels loaded with cell-free protein 
expression controls, gBLOCKs Q11, or gBLOCKs Phi29.  No detectable protein bands have yet 
been imaged that would suggest success at in-vitro synthesis of T-proteins from either Q11 or 




NEB-Express 'Quickstart' Expression of IDT 'gBLOCKs' of Phage Q11 or Phi29 T-proteinx. SDS-PAGE 
Gel1 
12%, Pre-cast 
TGX (BioRad)     
lane sample  
    
1 Marker 
    
2 QS- neg contr 
    
3 QS+ Pos contr 
    
4 QS Q11 
    
5 QS phi29 
    
6 Marker 
    
7 QS- neg contr 
    
8 QS+ Pos contr 
    
9 QS Q11 
    
10 QS phi29 
    
      
Gel2 
4-20%, Pre-cast 
TGX (BioRad)     
lane sample 
    
1 QS- neg contr 
    
2 Marker 
 
 3 QS+ Pos contr 
4 QS Q11 
5 QS phi29 
6 QS- neg contr 
7 Marker 
8 QS+ Pos contr 
9 QS Q11 
10 QS phi29 
      
      
 
Figure 9: SDS-PAGE analysis of NEB-Express 'Quickstart' Expression of IDT 'gBLOCKs' of Phage Q11 or 
Phi29 T-proteins.  Lane charts at left.   Upper-Standard 12% acrylamide.  Lower 4-20% acryamide gradient gel.  
Left-hand images: Coomassie-Blue stained.  Right-hand images: Silver-stained. 
 
The analysis by mass spectrometry is still a ‘work in progress’.  Data returned from the 
ISU Protein Facility (Q Exactive Quadrupole-Orbitrap Mass Spectrometer) listed a number (44 













both genomic DNA samples with T-proteins presumably attached. Keratin (hair & skin) proteins 
unfortunately also were detected in large numbers (14 for Phi29, 6 for Q11).  This is typical of 
facilities (the Walter lab) that have yet to take full ‘clean, dust-free’ measures for preparation of 
Mass-Spec’ bound samples.  Though there were several accession matches related to bacteria, no 
strong signal for T-protein was evident in the returned Mass-Spec’data.  UNI has recently 
purchased a similar Mass-Spec (Agilent Q-TOF LC/MS) through a Carver Grant. We will 




Table 1 – Protein ID output, Phi29, LC-MS/MS analysis – ISU.
  
Phi29 - LC-MS/MS….Description Biological Process Molecular Function
Lysyl endopeptidase OS=Pseudomonas aeruginosa (strain UCBPP-PA14) OX=208963 GN=prpL PE=1 SV=1met bolic process catalytic activity
Bacillopeptidase F OS=Bacillus subtilis (strain 168) OX=224308 GN=bpr PE=1 SV=2metabolic process catalytic activity
ATP synthase subunit b 1 OS=Granulibacter bethesdensis (strain ATCC BAA-1260 / CGDNIH1) OX=391165 GN=atpF1 PE=3 SV=2metabolic process;transport transporter activity
Keratin, type II cytoskeletal 1 OS=Homo sapiens OX=9606 GN=KRT1 PE=1 SV=6cell death;defense response;metabolic process;regulation of biological process;response to stimulus;transportcatalytic activity;motor activity; rotein binding;receptor activity;structural molecule activity
Keratin, type I cytoskeletal 9 OS=Homo sapiens OX=9606 GN=KRT9 PE=1 SV=3cell death;cell organization and biogenesis structural molecule activity
Keratin, type I cytoskeletal 10 OS=Homo sapiens OX=9606 GN=KRT10 PE=1 SV=6cell death;cell differentiation;metabolic process structural molecule activity
Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens OX=9606 GN=KRT2 PE=1 SV=2cell death;cell organization and biogenesis;cell proliferation;cellular component movement;metabolic processprote n binding;structural molecul  activity
Trypsin OS=Sus scrofa OX=9823 PE=1 SV=1 metabolic process catalytic activity;metal ion binding
Keratin, type I cytoskeletal 14 OS=Homo sapiens OX=9606 GN=KRT14 PE=1 SV=4cell death;cell differentiation;cell organization and biogenesis;response to stimuluspr t in b nding;struc ural o ecule activity
Keratin, type II cytoskeletal 5 OS=Homo sapiens OX=9606 GN=KRT5 PE=1 SV=3cell death;cell organization and biogenesis;metabolic processcatalytic activity;motor activity;protein binding;structural molecule activity
Keratin, type I cytoskeletal 16 OS=Homo sapiens OX=9606 GN=KRT16 PE=1 SV=4cell death;cell differentiation;cell organization and biogenesis;cell proliferation;cellular component movement;defense response;regulation of biological process;response to stimuluspr t in b nding;structural mol c e activity
Keratin, type II cytoskeletal 6A OS=Homo sapiens OX=9606 GN=KRT6A PE=1 SV=3cell death;cell differentiation;cell organization and biogenesis;defense response;metabolic process;regulation of biological process;response to stimuluspr t in b n ing;structural molecule activity
Keratin, type I cytoskeletal 17 OS=Homo sapiens OX=9606 GN=KRT17 PE=1 SV=2cell death;cell organization and biogenesis;regulation of biological process;response to stimulusprotein binding;receptor activity;signal transducer activity;structural molecule activity
Keratin, type I cytoskeletal 15 OS=Mus musculus OX=10090 GN=Krt15 PE=1 SV=2 protein binding;structural molecule activity
Desmoplakin OS=Homo sapiens OX=9606 GN=DSP PE=1 SV=3cell death;cell differentiation;cell organization and biogenesis;metabolic process;regulation of biological process;response to stimulus;transportcatalytic activi y;motor a tivity;protein binding;RNA binding; t uctural m lecule activity
Junction plakoglobin OS=Mus musculus OX=10090 GN=Jup PE=1 SV=3cell organization and biogenesis;cellular component movement;regulation of biological process;response to stimulusprotein binding;signal transducer activity;structural molecule activity
Serum albumin OS=Homo sapiens OX=9606 GN=ALB PE=1 SV=2cell communication;cell organization and biogenesis;metabolic process;regulation of biological process;response to stimulus;transportantioxidant activity;catalytic activity;DNA binding;metal i  binding;protein bi ding
Catenin beta-1 OS=Danio rerio OX=7955 GN=ctnnb1 PE=1 SV=1cell organization and biogenesis;regulation of biological process;response to stimulusprotein binding; ignal tran ducer activity
Cationic trypsin-3 OS=Rattus norvegicus OX=10116 GN=Try3 PE=2 SV=1metabolic process catalytic activity;metal ion binding
Dermcidin OS=Homo sapiens OX=9606 GN=DCD PE=1 SV=2defense response;metabolic process;response to stimuluscatalytic activity;protein binding;RNA binding
Immunoglobulin heavy constant gamma 1 OS=Homo sapiens OX=9606 GN=IGHG1 PE=1 SV=1cell orga ization and biogenesis;cellular component movement;defense response;metabolic process;regulation of biological process;response to stimulus;transportcatalytic ac ivity;metal ion binding;protein binding
Serum albumin OS=Bos taurus OX=9913 GN=ALB PE=1 SV=4cell communication;regulation of biological process;response to stimulus;transportDNA bi ding;metal ion binding
Keratinocyte proline-rich protein OS=Homo sapiens OX=9606 GN=KPRP PE=1 SV=1 protein binding
Keratinocyte proline-rich protein OS=Rattus norvegicus OX=10116 GN=Kprp PE=2 SV=1
Plakophilin-1 OS=Homo sapiens OX=9606 GN=PKP1 PE=1 SV=2cell death;cell organization and biogenesis;development;regulation of biological process;response to stimulus;transportprotein binding;signal transducer activity;structural molecule ctivity
Desmoglein-1 OS=Homo sapiens OX=9606 GN=DSG1 PE=1 SV=2cell death;cell organization and biogenesis;regulation of biological process;response to stimulus;transportmetal i n binding;protein binding
Protein Wnt-2b OS=Gallus gallus OX=9031 GN=WNT2B PE=1 SV=1cell differentiation;cell proliferation;development;regulation of biological process;response to stimulusprotein binding
Corneodesmosin OS=Pan troglodytes OX=9598 GN=CDSN PE=2 SV=1 protein binding
Thioredoxin OS=Pongo abelii OX=9601 GN=TXN PE=3 SV=3cellular homeostasis;metabolic process;regulation of biological process;response to stimulus;transportcatalytic activity
Desmocollin-1 OS=Homo sapiens OX=9606 GN=DSC1 PE=1 SV=2cell death;transport metal ion binding
Keratin, type II cuticular Hb4 OS=Homo sapiens OX=9606 GN=KRT84 PE=2 SV=2cell death;cell organization and biogenesis;regulation of biological processcatalytic activity;motor activity;protein binding;structural molecule activity
Immunoglobulin kappa constant OS=Homo sapiens OX=9606 GN=IGKC PE=1 SV=2cell organization and biogenesis;cellular component movement;defense response;metabolic process;regulation of biological process;response to stimulus;transportcatalytic ac ivity;protein binding
Keratin, type I cuticular Ha3-I OS=Homo sapiens OX=9606 GN=KRT33A PE=2 SV=2cell death;metabolic process catalytic activity;motor activity;structural molecule activity
Archaeal Lon protease OS=Archaeoglobus fulgidus (strain ATCC 49558 / VC-16 / DSM 4304 / JCM 9628 / NBRC 100126) OX=224325 GN=AF_0364 PE=1 SV=1met bolic process;regulation of biological process;response to stimuluscatalytic activity;DNA binding;nucleotide binding;protein binding
tRNA modification GTPase MnmE OS=Klebsiella pneumoniae (strain 342) OX=507522 GN=mnmE PE=3 SV=1metabolic process;regulation of biological process;response to stimuluscatalytic activity;metal ion binding;nucleotide binding
Galectin-7 OS=Homo sapiens OX=9606 GN=LGALS7 PE=1 SV=2cell death
Glyceraldehyde-3-phosphate dehydrogenase OS=Pongo abelii OX=9601 GN=GAPDH PE=2 SV=3cell death;cell organization and biogenesis;metabolic process;regulation of biological processcatalytic activity;nucleotide binding;protein binding
Serpin B12 OS=Homo sapiens OX=9606 GN=SERPINB12 PE=1 SV=1cell differentiation;regulation of biological process;transportenzyme egulator activity;protein binding
Fructose-bisphosphate aldolase 4, cytosolic OS=Arabidopsis thaliana OX=3702 GN=FBA4 PE=2 SV=1metabolic process catalytic activity
Replication factor C small subunit OS=Methanothermobacter thermautotrophicus (strain ATCC 29096 / DSM 1053 / JCM 10044 / NBRC 100330 / Delta H) OX=187420 GN=rfcS PE=1 SV=1metabolic process;response to stimulus catalytic activity;DNA binding;nucleotide binding
Skin-specific protein 32 OS=Homo sapiens OX=9606 GN=XP32 PE=1 SV=1cell differentiation;metabolic process structural molecule activity
Ankycorbin OS=Mus musculus OX=10090 GN=Rai14 PE=1 SV=1cell differentiation;cell organization and biogenesis;transportcatalytic activity;motor activity;protein binding













Q11 - LC-MS/MS….Description Biological Process Molecular Function
Lysyl endopeptidase OS=Pseudomonas aeruginosa (strain UCBPP-PA14) OX=208963 GN=prpL PE=1 SV=1metabolic process catalytic activity
Elongation factor G OS=Bacillus cereus (strain ZK / E33L) OX=288681 GN=fusA PE=3 SV=1metabolic process catalytic activity;nucleotide binding;RNA binding
Cobyric acid synthase OS=Carboxydothermus hydrogenoformans (strain ATCC BAA-161 / DSM 6008 / Z-2901) OX=246194 GN=cobQ PE=3 SV=1metabolic process catalytic activity
ATP synthase subunit beta OS=Lactobacillus brevis (strain ATCC 367 / JCM 1170) OX=387344 GN=atpD PE=3 SV=1metabolic process;transport catalytic activity;nucleotide binding;transporter activity
tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG OS=Lactobacillus acidophilus (strain ATCC 700396 / NCK56 / N2 / NCFM) OX=272621 GN=mnmG PE=3 SV=1metabolic process cat lytic activity;nucleotide binding
Keratin, type II cytoskeletal 1 OS=Homo sapiens OX=9606 GN=KRT1 PE=1 SV=6cell death;defense response;metabolic process;regulation of biological process;response to stimulus;transportcatalytic activ ty;motor activity;protein binding;receptor activity;structural molecule activity
Keratin, type I cytoskeletal 9 OS=Homo sapiens OX=9606 GN=KRT9 PE=1 SV=3cell death;cell organization and biogenesis structural molecule activity
Serum albumin OS=Bos taurus OX=9913 GN=ALB PE=1 SV=4cell communication;regulation of biological process;response to stimulus;transportDNA binding;metal ion bindi g
Keratin, type I cytoskeletal 10 OS=Homo sapiens OX=9606 GN=KRT10 PE=1 SV=6cell death;cell differentiation;metabolic process structural molecule activity
Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens OX=9606 GN=KRT2 PE=1 SV=2c ll death;cell organization and biogenesis;cell proliferation;cellular component movement;metabolic processprotein bi ding;stru tural molecule activity
Trypsin OS=Sus scrofa OX=9823 PE=1 SV=1 metabolic process catalytic activity;metal ion binding
Keratin, type I cytoskeletal 14 OS=Homo sapiens OX=9606 GN=KRT14 PE=1 SV=4cell death;cell differentiation;cell organization and biogenesis;response to stimulusprotein binding; tructural molec le activity
Cyclin-dependent kinase C-2 OS=Arabidopsis thaliana OX=3702 GN=CDKC-2 PE=1 SV=2metabolic process;regulation of biological process;response to stimuluscatalytic activity;nucleotide binding;protein binding
Proteinase K OS=Parengyodontium album OX=37998 GN=PROK PE=1 SV=2metabolic process catalytic activity;metal ion binding
Keratin, type II cytoskeletal 5 OS=Homo sapiens OX=9606 GN=KRT5 PE=1 SV=3cell death;cell organization and biogenesis;metabolic processcatalytic activity;motor activity;protein binding;structural molecule activity
Glycinin G4 OS=Glycine max OX=3847 GN=GY4 PE=1 SV=2
Cationic trypsin-3 OS=Rattus norvegicus OX=10116 GN=Try3 PE=2 SV=1metabolic process catalytic activity;metal ion binding
Putative 8-amino-7-oxononanoate synthase OS=Magnetospirillum magneticum (strain AMB-1 / ATCC 700264) OX=342108 GN=bioF PE=3 SV=1metabo ic process catalytic activity
Proteinase R OS=Parengyodontium album OX=37998 GN=PROR PE=1 SV=1metabolic process;transport catalytic activity;metal ion binding
Ubiquitin-40S ribosomal protein S27a OS=Drosophila melanogaster OX=7227 GN=RpS27A PE=1 SV=2metabolic process metal ion binding;protein binding;structural molecule activity
Bromodomain-containing protein 4A OS=Xenopus laevis OX=8355 GN=brd4-a PE=2 SV=1cell organization and biogenesis;metabolic process;regulation of biological processprotein binding
Sec-independent protein translocase protein TatB OS=Maricaulis maris (strain MCS10) OX=394221 GN=tatB PE=3 SV=1transport ransporter activity
Dermcidin OS=Homo sapiens OX=9606 GN=DCD PE=1 SV=2defense response;metabolic process;response to stimuluscatalytic activity;protein binding;RNA binding
Calmodulin-like protein 5 OS=Homo sapiens OX=9606 GN=CALML5 PE=1 SV=2regulation of biological process;response to stimulus;transportmetal ion binding;protein binding
60 kDa chaperonin OS=Rhodobacter sphaeroides (strain ATCC 17025 / ATH 2.4.3) OX=349102 GN=groL PE=3 SV=1metabolic process nucleotide binding
Vacuolar membrane-associated protein IML1 OS=Coccidioides immitis (strain RS) OX=246410 GN=IML1 PE=3 SV=2regulation of b ological process;response to stimulus





 The results of the enzyme digests and PCR amplification did not show any concrete 
biochemical evidence of a covalently bonded protein on the 5’ end of Q11 DNA. However, the 
data did not disprove the existence of a protein. The enzyme digests could have been 
unsuccessful for a few reasons. For example, the fragments resulting from the EcoRI and HindIII 
endonucleases may have been too small to identify on a standard gel electrophoresis. If so, the 
fragment could have been run off the gel and not have been visible. At the same time, the protein 
could have been detached from the DNA at some point in the preparation process. Therefore, a 
fragment with a T-protein could not be identified. Because of these reasons, I adjusted my 
research approach to PCR and expression of the gene itself.  
 PCR was successful with phi29 and the positive control. In Figure 5, one can see the gel 
of the PCR and see that some bands are visible at the expected size range, but Q11 was 
consistently unsuccessful. It is possible that the primers designed for the specific gene were 
oriented in the wrong direction, therefore, not expressing the gene correctly. The samples were 
sent out for testing, however, due to time constraints we were not able to get the results and 
adjust the primers. We could still compare the phi29 and suspected Q11 T-protein in other ways.   
 When looking at the Dot Plots in the results section, it is not unreasonable to assume that 
the phi29 T-protein and Q11 suspected T-protein are overall not similar to one another. The plots 
in Figure 6 shows large gaps in overlap between the amino acid sequences of the two proteins. 
When compared to other Bacillus phages, Q11 T-protein is much more similar to VioletteMad 
rather than phi29. Therefore, it can be assumed that phi29 and Q11 do not have a similar protein 




The expression of DNA-synthesized (gBLOCKs) T-protein did not produce a band from 
the gene product . However, because the positive controls were present on the gel, it can be 
assumed the problem was with the expression of the gene itself. This could be for a variety of 
reasons, including low concentrations of DNA or problems with the design of the expression 
primers. The MS data collected from the lab showed limited results based on contamination and 
limited time to send in more data. Therefore, limited conclusion could be drawn from both 





















 Q11 is heavily suspected to have a covalently bonded protein on the 5’ end of its double 
stranded DNA, however, it has yet to be expressed or characterized. Studying this protein is 
important because it is involved in replication of the phage and infections of host. The research 
done does not provide biochemical evidence for a protein at the 5’ end of the DNA, however, 
there is evidence to support the protein is not similar to phi29’s 5’ covalently bonded T-protein. 
One limitation to this project was primers for PCR amplification not working consistently 
enough to draw a conclusion. That being said, time constraints prevented further investigation 
into why the primers were not working and redesigning them. Furthermore, time also inhibited 
further research into expressing the protein and clear MS data. Future research into this topic 
should focus on finding biochemical evidence to explicitly demonstrate a T-protein on Q11 or 
the absence of one. Bacteriophage research is important to the future understanding of the 
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